Cite
HARVARD Citation
Alifrangis, C. et al. (2018). Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours—A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.' by Loriot and colleagues. European journal of cancer. pp. 102-103. [Online].